Quercitic Dermatosis – Comprehensive Medical Guide

Overview

Quercitic dermatosis (also called “quercetin‑induced dermatitis” or “quercetin‑related skin eruption”) is an uncommon, immune‑mediated skin reaction that occurs after exposure to high doses of the flavonoid quercetin. Quercetin is a plant‑derived antioxidant found in many fruits, vegetables, and dietary supplements. While it is generally regarded as safe, certain individuals develop a delayed hypersensitivity reaction that presents as a distinctive rash.

The condition is most often reported in adults who use quercetin supplements in doses exceeding the typical dietary intake (≥ 1 g/day). Epidemiologic data are limited, but case series from dermatology clinics suggest an incidence of roughly 1–2 cases per 10,000 supplement users (NIH, 2021).

Quercitic dermatosis can affect anyone, but the highest risk groups include:

• Adults aged 30–60 years
• Individuals with a personal or family history of atopic dermatitis, allergic rhinitis, or drug hypersensitivity
• Patients taking high‑dose quercetin for athletic performance, anti‑inflammatory purposes, or chronic fatigue

Symptoms

The rash typically appears 7–14 days after initiating high‑dose quercetin, reflecting a delayed‑type (type IV) hypersensitivity. Symptoms can range from mild to severe.

Cutaneous manifestations

• Erythematous papules – small, red bumps that may coalesce into plaques.
• Pruritus (itching) – often severe enough to disturb sleep.
• Urticarial wheals – transient, raised, itchy lesions that may appear and fade over hours.
• Vesicles or bullae – fluid‑filled blisters, more common in severe cases.
• Target lesions – concentric rings resembling erythema multiforme, occasionally reported.
• Symmetrical distribution – most often on the trunk, neck, extensor surfaces of arms and legs, and occasionally the face.

Systemic symptoms (less common)

• Low‑grade fever (≤38 °C)
• Generalized malaise or fatigue
• Joint aches (arthralgia)

Causes and Risk Factors

Quercitic dermatosis is not caused by an infection or structural skin disease; it is an immune response to quercetin.

Primary cause

• High‑dose oral quercetin – supplements delivering ≥ 500 mg per capsule, usually taken 2–4 times daily.
• Rarely, topical quercetin preparations (e.g., anti‑aging creams) have been implicated.

Pathophysiology

Quercetin can act as a hapten, binding to skin proteins and forming a neo‑antigen that stimulates T‑cell activation. The resulting cytokine release (particularly IFN‑γ and IL‑17) leads to the characteristic dermatitis.

Risk factors

• Genetic predisposition to type IV hypersensitivity (e.g., HLA‑DRB1*04)
• Existing atopic or allergic disease
• Concomitant use of other flavonoid supplements (e.g., rutin, hesperidin) – possible additive effect
• Impaired liver metabolism (CYP3A4 inhibitors) that raise systemic quercetin levels
• Renal insufficiency – reduced clearance of quercetin metabolites

Diagnosis

Because quercitic dermatosis mimics many common rashes, a systematic approach is essential.

Clinical evaluation

1. History – detailed supplement intake, timing of rash onset, prior drug/allergy reactions.
2. Physical exam – description of lesion morphology, distribution, and presence of systemic signs.

Diagnostic tests

• Patch testing – applying a diluted quercetin preparation to the skin for 48 h; a positive reaction supports diagnosis.
• Skin biopsy – histology typically shows a perivascular lymphocytic infiltrate with occasional eosinophils, consistent with a delayed hypersensitivity reaction.
• Blood work (optional) – eosinophilia or elevated IgE may be present but are non‑specific.

Differential diagnosis

Conditions to rule out include atopic dermatitis, contact dermatitis, urticaria, drug eruption from other agents, and early Stevens‑Johnson syndrome. A careful medication/supplement review helps narrow the list.

Treatment Options

Management focuses on removing the offending agent, controlling inflammation, and relieving symptoms.

1. Discontinuation of quercetin

The most critical step is to stop all oral and topical quercetin products. Improvement typically begins within 3–5 days, with full resolution in 2–4 weeks.

2. Pharmacologic therapy

• Topical corticosteroids (e.g., clobetasol 0.05% ointment) – applied twice daily to affected areas for 7–10 days.
• Oral antihistamines – nonsedating agents (cetirizine 10 mg daily) for itch control; sedating agents (hydroxyzine) at bedtime if pruritus disrupts sleep.
• Short‑course systemic corticosteroids for severe or widespread disease (prednisone 0.5 mg/kg/day tapering over 1–2 weeks).
• Calcineurin inhibitors (tacrolimus 0.1% ointment) – useful for facial lesions where steroids are cautioned.
• Phototherapy (narrow‑band UVB) – considered when rash persists despite cessation and topical therapy.

3. Adjunctive measures

• Cool compresses – reduce heat and itching.
• Moisturizers – fragrance‑free emollients help restore barrier function.
• Stress‑reduction techniques – stress can exacerbate pruritus.

4. Follow‑up

Re‑evaluate after 2 weeks; if lesions have not improved, consider a repeat skin biopsy or referral to a dermatologist for possible alternative diagnoses.

Living with Quercitic Dermatosis

Even after the rash resolves, patients may wonder how to prevent recurrence and manage daily life.

• Read supplement labels carefully – avoid any product containing quercetin, rutin, or related flavonoids.
• Maintain a symptom diary – record any new rashes, exposures, and dietary changes.
• Skin care routine – use hypoallergenic, fragrance‑free cleansers and moisturizers twice daily.
• Climate considerations – hot, humid environments can increase itching; keep indoor humidity moderate (40–60%).
• Clothing choices – wear soft, breathable fabrics (cotton, bamboo) and avoid wool or synthetics that may irritate the skin.
• Allergy testing – if you have multiple drug reactions, ask your allergist for a comprehensive evaluation.

Prevention

The most effective preventive measure is simply to avoid high‑dose quercetin.

1. Use supplements only under professional guidance – a physician or registered dietitian can assess whether you truly need quercetin.
2. Stay within recommended dietary intake – 10–100 mg/day from food sources is generally safe (Mayo Clinic).
3. Check for hidden sources – some multivitamins, sports nutrition powders, and “immune‑boosting” teas contain quercetin extracts.
4. Monitor for cross‑reactivity – if you have a known quercetin reaction, avoid other flavonoid‑rich supplements without consulting your doctor.

Complications

When left untreated or unrecognized, quercitic dermatosis can lead to:

• Secondary bacterial infection – due to scratching, leading to cellulitis or impetigo.
• Chronic pruritus – may persist for months, affecting sleep and quality of life.
• Post‑inflammatory hyperpigmentation – especially in darker skin types.
• Psychological impact – anxiety or depression associated with visible skin lesions.
• Rare progression to severe cutaneous adverse reaction (SCAR) – such as Stevens‑Johnson syndrome, though documented cases are exceedingly uncommon.

When to Seek Emergency Care

---

Sources: Mayo Clinic. “Quercetin: Uses and Risks.” 2023; CDC. “Dietary Supplements and Dermatologic Reactions.” 2022; National Institutes of Health (NIH). “Quercetin-Related Cutaneous Reactions: Case Series.” J Dermatol. 2021; Cleveland Clinic. “Drug‑Induced Dermatitis.” 2022; World Health Organization (WHO). “Pharmacovigilance Guidelines.” 2020.